The World's No 1 Selling Brand1
An important message from Clearblue®
We are aware of videos circulating about Clearblue® pregnancy tests and the tablet found inside.Clearblue® pregnancy tests do NOT contain Plan B. All our tests contain a small desiccant tablet which is included to absorb moisture and should not be eaten.
If accidentally ingested please seek medical advice and for any further questions contact our careline at 1-800-321-3279.
Clearblue®
Pregnancy and Ovulation Tests
Clearblue® tests can help you find the answers you are looking for by providing clear results with accuracy and convenience. Our current range of products includes pregnancy tests and ovulation tests.
Over the past 35 years over 23,000 volunteers have been involved in Clearblue® clinical research in more than 140 trials. We are committed to helping you manage your reproductive health.
How to get pregnant ?
You can only get pregnant if you have unprotected sex during the few days each menstrual cycle leading up to and including the day of ovulation. So, if you are trying to conceive Clearblue® Ovulation Tests enable you to identify these fertile days helping you to get pregnant faster. If you want to get an approximation for when you ovulate, you can also use our ovulation calculator.
Am I pregnant ?
Various early pregnancy symptoms can indicate you might be pregnant. They differ from woman to woman and from pregnancy to pregnancy. If you are pregnant, you may notice one or more of these symptoms or none at all. That’s why Clearblue® Early Digital and Clearblue® Early Detection Pregnancy Tests can be used up to 6 days before your missed period, which is 5 days before the day you would expect your period to start (your ‘expected period’ day).2
Over 35 years of World firsts from the pregnancy and fertility category experts. The Clearblue® brand has a history of more than 35 years of innovation, giving women confidence and reassurance. That’s why over 20 million women choose our products every year and over 30 million women visit our website to find the answers they need.
Our mission
We put women right at the heart of everything we do – from education and technological development through to design, research, clinical studies, field trials and testing. Our mission is to transform the way women manage their reproductive health.
Our history
For over 35 years we have helped millions of women across the globe by delivering accurate & clear answers at life-changing moments. Whether trying to conceive or thinking they may be pregnant, we have been supporting women with innovative Clearblue® products to manage their reproductive life.
- 1988
First one-step pregnancy test
- 1989
Launch of first one-step ovulation test
- 2003
World’s first digital pregnancy test by Clearblue®
- 2015
World’s first Advanced Fertility Monitor with touch-screen technology
- … all from Clearblue®
Clearblue® careline
Our team of trained Clearblue® careline advisors are here to help. Whether you have a simple technical question about one of our products or want friendly advice to help you on your journey to parenthood, our dedicated team of professionals is here for you.
Clearblue® Experts
We engage with a range of independent Healthcare Professionals to continue to ensure our scientific and educational understanding is up-to-date with the latest scientific and clinical trends. Our independent experts also critique our Clearblue® product-related activities. Our Advisory Board is made up of a range of fertility, pregnancy, contraception and sexual health experts with a broad range of experience.
Dr Kurt Barnhart is Vice Chair for Clinical Research and the Director of the Women’s Health Clinical Research Center for the Department of Obstetrics and Gynecology in the Perelman School of Medicine at the University of Pennsylvania. He is the William Shippen, Jr. Professor Obstetrics and Gynecology and Epidemiology. He received his medical degree at Mount Sinai School of Medicine, and his M.S.C.E. degree (Clinical Epidemiology and Biostatistics) at the University of Pennsylvania. He is a board certified in obstetrics and gynecology as well as reproductive endocrinology and infertility.
Dr. Suruchi Thakore is a physician specializing in Reproductive Endocrinology and Infertility. She is the Medical Director for the West Michigan offices of IVF Michigan and Ohio Fertility Centers. Prior to moving to Michigan, Dr. Thakore was the Division Director of the University of Cincinnati Division of Reproductive Endocrinology and Infertility. Her clinical interests include third party reproduction, fertility preservation for single women and oncology patients, polycystic ovarian syndrome, and reproductive endocrine disorders. Her current research is focused on quality and performance improvement in the clinical setting, optimization of fertility procedures, social egg freezing, and fertility preservation. Dr. Thakore is a member of AMA, ACOG, SREI and ASR.
Monica Moore is the founder of “Fertile Health, LLC”, a consulting company created to train new nurses in reproductive endocrinology and to encourage nutritional practices into fertility centers. She is a Women's Health Nurse Practitioner, and was one of the nurse managers at Reproductive Medicine Associates of Connecticut (RMA of CT) and continues to work as a consultant for them. Prior to joining RMA, Monica was the donor nurse coordinator at the Atlanta Center for Reproductive Medicine. Monica's first job in reproductive endocrinology was at Cornell Center for Reproductive Medicine and Infertility 20 years ago. Monica's passion lies in nutritional interventions for couples attempting pregnancy and for women diagnosed with PCOS.
Sarah L. Berga, MD is Professor and Chair, Department of Obstetrics and Gynecology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo SUNY. Dr. Berga received her BAS from the University of Virginia and her MD from the University of Virginia School of Medicine. She completed her residency in Obstetrics and Gynecology at Harvard University followed by a fellowship in Reproductive Endocrinology at the University of California San Diego School of Medicine.
Dr Julie Oliver completed her medical degree at the University of Leeds and after training in obstetrics and gynecology she made the shift to general practice.
Dr Oliver is now an accredited GP with Special Interest (GPwSI) in Gynaecology working within North Durham CCG and has set up a business called Durham Gynae which is commissioned to provide GPwSI services. She is also an accredited trainer for the Faculty of Sexual and Reproductive Healthcare.
Professor William Ledger is Head of Discipline of Obstetrics and Gynaecology of the Faculty of Medicine at the University of New South Wales, Director of Reproductive Medicine and Senior Staff Specialist at the Royal Hospital for Women and a fertility specialist at City Fertility in Sydney. He founded the Fertility and Research Centre (FRC), a joint venture between University of New South Wales and South East Sydney Local Health District as a centre for translational research in reproductive biology and reproductive medicine. The FRC has Government funding to provide a Statewide service in oncofertility: preservation of sperm, oocytes and embryos for young people prior to gonadotoxic chemotherapy or radiotherapy. The centre is unique in Australia and is currently running three randomised trials, two observational studies and an early stage translational project to improve techniques for in vitro maturation of human oocytes. The work of the centre has generated two patents. He is Chair of the RANZCOG Research Committee and a member of the Scientific Advisory Committee of the Fertility Society of Australia. Recently, he was a member of an NHMRC Working Party to review national guidelines on ethics and ART and Chair of the MBS Working Party on costs of ART.
- In home pregnancy & fertility tests. Based on international sales in nearly 20 countries compiled using independent market research data.
- Clearblue® Early Digital and Clearblue® Early Detection provide early detection of the pregnancy hormone (hCG).
Clearblue® Early Digital can detect 78% and Clearblue® Early Detection can detect 77% of pregnancies 6 days before the missed period (5 days before the expected period). - Only a healthcare professional can confirm your menopause stage.
- Natural Cycles° is 93% effective with typical use which means if 100 women use this method for 1 year, we expect 7 will become pregnant.